Verona Pharma Plc Verona Pharma (NASDAQ: VRNA) Inks Collaboration Agreement with Nuance Pharma Verona Pharma plc (NASDAQ: VRNA) disclosed that it has inked an agreement with Nuance Pharma. The firm has provided the rights to develop and commercialize ensifentrine in Greater China.
Verona Pharma Plc Verona Pharma (NASDAQ: VRNA) to Share First Quarter 2021 Financial Results Verona Pharma plc (NASDAQ: VRNA) disclosed that it is planning to report its financial results for the three months completed March 31, 2021, on Thursday, April 29, 2021.
